Every material Form 8-K Janus Living, Inc. has filed with the SEC since August 12, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Janus Living, Inc. closed a registered underwritten public offering of 30,187,500 Class A-1 common shares on November 6, 2026, including the underwriters' full exercise of their option to buy 3,937,500 additional shares. The filing does not state the offering price or the proceeds, and the issuance adds shares that will dilute existing holders' ownership.
Offering closed November 6, 2026 with 30,187,500 Class A-1 common shares, $0.01 par value
Underwriters exercised their option in full for 3,937,500 additional shares
Underwriting Agreement dated November 4, 2026 with BofA Securities, J.P. Morgan, Wells Fargo and Goldman Sachs as representatives
Janus Living reported third quarter 2026 results with revenue of $268 million, up 78% from a year earlier, and FFO as Adjusted of $0.25 per share, up 46%. The company posted a net loss of $(0.02) per share, compared with diluted income of $0.01 per share a year earlier, and cut its full-year 2026 diluted earnings per share guidance while raising its FFO as Adjusted guidance.
Q3 2026 net loss of $(0.02) per share versus $0.01 per share in Q3 2025; FFO as Adjusted rose to $0.25 per share from $0.17
Full-year 2026 diluted EPS guidance lowered to $0.08 to $0.10 from $0.34 to $0.37, mainly due to depreciation and amortization on acquisitions
Full-year 2026 FFO as Adjusted guidance raised to $0.97 to $0.99 per share from $0.95 to $0.98
Completed about $1.75 billion of senior housing acquisitions in Q3 and about $370 million more through October 30, 2026
Janus Living and its operating company amended and restated their Original Credit Agreement with Bank of America, N.A. as administrative agent, effective September 17, 2026. The revolving credit facility rises from $500 million to $1.25 billion, and the $100 million delayed draw term loan facility is terminated. The filing says the terms are otherwise generally consistent with the original agreement.
Revolving credit facility increases from $500 million to $1.25 billion.
Company can increase the revolver and/or add incremental term loans up to an aggregate $1.75 billion, subject to customary requirements including additional lender commitments.
$100 million delayed draw term loan facility outstanding under the original agreement is terminated.
Original Credit Agreement was dated March 23, 2026; the amended agreement is dated September 17, 2026.
Janus Living, Inc. closed a registered underwritten public offering of 18,400,000 Class A-1 common shares on August 12, 2026, including 2,400,000 shares sold under the underwriters' option, which was exercised in full. The filing does not state the offering price or net proceeds, so the dollar size of the raise is not disclosed here.
Offering of 18,400,000 Class A-1 common shares closed August 12, 2026, including 2,400,000 option shares
Underwriting Agreement dated August 10, 2026, with BofA Securities, J.P. Morgan Securities and Wells Fargo Securities as representatives
Sold under Form S-11 registration statement (File No. 333-298182); Healthpeak Investment Management, LLC is the external manager
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Janus Living, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →